Ultragenyx Pharmaceutical
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ultragenyx Pharmaceutical's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20% to $434,249,000. The net income raised on -$606,639,000 and profit margin reached -140%. Total operating expenses were $958,248,000.
Profit Margin
| 2014 | 0 | -59.80M | |
|---|---|---|---|
| 2015 | 0 | -145.61M | |
| 2016 | 133K | -245.87M | -184867.67% |
| 2017 | 2.61M | -302.13M | -11567.34% |
| 2018 | 51.49M | -197.61M | -383.75% |
| 2019 | 103.71M | -402.72M | -388.31% |
| 2020 | 271.03M | -186.56M | -68.84% |
| 2021 | 351.40M | -454.02M | -129.2% |
| 2022 | 363.32M | -707.42M | -194.71% |
| 2023 | 434.24M | -606.63M | -139.7% |
RARE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 434.24M | 363.32M | 351.40M | 271.03M | 103.71M | 51.49M | 2.61M | 133K | 0 | 0 |
Cost of revenue | 45.20M | 28.32M | 16.00M | 6.12M | 9.00M | 1.14M | 1K | 0 | 1.38M | 0 |
Gross profit | 389.04M | 335.00M | 335.39M | 264.90M | 94.70M | 50.34M | 2.61M | 133K | -1.38M | 0 |
Operating exp. | ||||||||||
Research and development | 648.44M | 705.78M | 497.15M | 412.08M | 357.35M | 293.99M | 231.64M | 183.20M | 114.73M | 45.96M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 958.24M | 983.92M | 717.13M | 595.01M | 518.87M | 421.72M | 331.55M | 248.14M | 147.73M | 56.77M |
Operating income | -569.20M | -648.91M | -381.73M | -330.11M | -424.17M | -371.37M | -328.94M | -248.00M | -147.73M | -56.77M |
Other income (expenses), net | -39.25M | -52.80M | -71.24M | 144.75M | 24.72M | 174.27M | 10.60M | 2.16M | 2.12M | -3.02M |
Income before tax | -608.46M | -701.72M | -452.98M | -185.35M | -399.44M | -197.09M | -318.33M | -245.83M | -145.61M | -59.80M |
Income tax expense | -1.82M | 5.69M | 1.04M | 1.20M | 3.28M | 514K | -16.19M | 35K | -2.32M | -684K |
Net income | -606.63M | -707.42M | -454.02M | -186.56M | -402.72M | -197.61M | -302.13M | -245.87M | -145.61M | -59.80M |
Earnings per share | ||||||||||
Basic EPS | -8.25 | -10.12 | -6.7 | -3.07 | -7.12 | -3.97 | -7.12 | -6.21 | -3.96 | -2.08 |
Diluted EPS | -8.25 | -10.12 | -6.7 | -3.07 | -7.12 | -3.97 | -7.12 | -6.21 | -3.96 | -2.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |